Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Divine Skin, a biotechnology company, is expected to launch a new consumer health-care division to make use of the pharmaceutical research it has conducted during the development of topical treatments for hair and skin.
Subscribe to our email newsletter
Divine Skin’s new division is expected to target both over-the-counter (OTC) and prescription drug sectors.
Divine Skin claimed that its research conducted in hair loss and other common skin conditions showed high-performance topical solutions for men and women.These include therapies to control acne, reduce the appearance of facial aging, restore growth and radiance to hair, suppress dandruff and unwanted hair and support feminine hygiene.
Daniel Khesin, founder and CEO of Divine Skin, said: “The core principle of Divine Skin has always been to treat skin and scalp conditions through multiple pathways. This multivariate approach is expected to lead us toward innovations in the OTC and prescription categories as well, resulting in more effective therapies while reducing biological toxicity.”